Cargando…
Development of an (123)I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease
OBJECTIVE(S): We recently developed a new uptake index method for (123)I-metaiodobenzylguanidine ((123)I-MIBG) heart uptake measurements by using planar images (radioisotope angiography and planar image) for the diagnosis of Lewy body disease (LBD), including Parkinson’s disease (PD) and dementia wi...
Autores principales: | Kamiya, Yoshito, Ota, Satoru, Tanaka, Yuta, Yamashita, Kosuke, Takaki, Akihiro, Ito, Shigeki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038978/ https://www.ncbi.nlm.nih.gov/pubmed/29998146 http://dx.doi.org/10.22038/aojnmb.2018.10595 |
Ejemplares similares
-
Uptake Index of (123)I-metaiodobenzylguanidine Myocardial Scintigraphy for Diagnosing Lewy Body Disease
por: Kamiya, Yoshito, et al.
Publicado: (2017) -
Autopsy Validation of the Diagnostic Accuracy of (123)I-Metaiodobenzylguanidine Myocardial Scintigraphy for Lewy Body Disease
por: Matsubara, Tomoyasu, et al.
Publicado: (2022) -
(123)I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review
por: Chung, Eun Joo, et al.
Publicado: (2015) -
HIV Dementia with a Decreased Cardiac (123)I-metaiodobenzylguanidine Uptake Masquerading as Dementia with Lewy Bodies
por: Kurihara, Masanori, et al.
Publicado: (2018) -
(123)I‐Metaiodobenzylguanidine Myocardial Scintigraphy in Discriminating Degenerative Parkinsonisms
por: Catalan, Mauro, et al.
Publicado: (2021)